Madrigal Pharmaceuticals' Series D Round

Madrigal Pharmaceuticals raised a round of funding on November 24, 2004.

Madrigal Pharmaceuticals (Nasdaq: MGDL), formerly Synta Pharmaceuticals, is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathw…

Articles about Madrigal Pharmaceuticals' Series D Round: